5 Cheap Pharmaceutical Stocks For 2021

Page 5 of 5

1. Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD)

Number of Hedge Fund Holders: 26

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) is a Boston-based firm that concentrates on the development and commercialization of gastrointestinal (GI) products. The products that the company offers include linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome. The firm is also rumored to be developing IW-3300, a GC-C agonist, which is in pre-clinical development for the treatment of visceral pain conditions. The company was founded in 1998 and is placed first on our list of 10 best pharmaceutical stocks for 2021. 

It has a market cap of more than $1.6 billion and posted an annual revenue of more than $380 million in December 2020, down from the $428 million posted the previous year. The 52-week share price range of the firm is $12.5-$8.6. Earlier today, the shares of Ironwood were trading at $10.8. In February, the company announced that CEO Mark Mallon would be stepping down from his role. Shares of the company had soared earlier this year as it posted quarterly earnings that had beaten Wall Street estimates. 

As of the end of the fourth quarter, there were 26 hedge funds in Insider Monkey’s database that held stakes in IRWD, compared to 24 funds in the third quarter. Sarissa Capital Management, with 14.04 million shares of IRWD, is the biggest stakeholder in the company.

You can also take a peek at 10 Best Biotech Stocks To Buy For 2021, and Top 10 Best Freelancing Platforms and Websites for 2021.

Page 5 of 5